UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies

Journal of oncology, 2019, Vol.2019 (2019), p.1-36

2019

Volltextzugriff (PDF)

Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment

Journal of oncology, 2019, Vol.2019 (2019), p.1-12

2019

Volltextzugriff (PDF)

HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia

Journal of oncology, 2019, Vol.2019 (2019), p.1-11

2019

Volltextzugriff (PDF)

Identification of an Evolutionarily Conserved Family of Inorganic Polyphosphate Endopolyphosphatases

The Journal of biological chemistry, 2011-09, Vol.286 (37), p.31966-31974

2011

Volltextzugriff (PDF)

Targeted Therapies for Pediatric AML: Gaps and Perspective

Frontiers in pediatrics, 2019-11, Vol.7, p.463-463

2019

Volltextzugriff (PDF)

Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias

International journal of molecular sciences, 2020-08, Vol.21 (17), p.6251

2020

Volltextzugriff (PDF)

The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis

Frontiers in physiology, 2021-10, Vol.12, p.745032-745032

2021

Volltextzugriff (PDF)

B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?

Cancers, 2020-11, Vol.12 (12), p.3498

2020

Volltextzugriff (PDF)

Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML

Cancers, 2020-07, Vol.12 (7), p.1972

2020

Volltextzugriff (PDF)

Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway

Journal of hematology and oncology, 2016-10, Vol.9 (1), p.114-16, Article 114

2016

Volltextzugriff (PDF)

hGATA1 Under the Control of a μLCR/β-Globin Promoter Rescues the Erythroid but Not the Megakaryocytic Phenotype Induced by the Gata1low Mutation in Mice

Frontiers in genetics, 2021-10, Vol.12

2021

Volltextzugriff (PDF)

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors

Frontiers in oncology, 2022-08, Vol.12, p.901132-901132

2022

Volltextzugriff (PDF)

Exploiting Clonal Evolution to Improve the Diagnosis and Treatment Efficacy Prediction in Pediatric AML

Cancers, 2021-04, Vol.13 (9), p.1995

2021

Volltextzugriff (PDF)

Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene

Journal of hematology and oncology, 2017-01, Vol.10 (1), p.26-26, Article 26

2017

Volltextzugriff (PDF)

Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia

Current cancer drug targets, 2013-09, Vol.13 (7), p.791-810

2013

Volltextzugriff (PDF)

Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis

Haematologica (Roma), 2011-04, Vol.96 (4), p.552-557

2011

Volltextzugriff (PDF)

The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party

Haematologica (Roma), 2010-10, Vol.95 (10), p.1683-1690

2010

Volltextzugriff (PDF)

Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting

Biochimica et biophysica acta, 2016-03, Vol.1863 (3), p.449-463

2016

Volltextzugriff (PDF)

Successes and Challenges for Diagnosis and Therapy of Acute Leukemia

Journal of oncology, 2019, Vol.2019, p.3408318-2

2019

Volltextzugriff (PDF)

Autophagy in acute leukemias: A double-edged sword with important therapeutic implications

Biochimica et biophysica acta, 2015-01, Vol.1853 (1), p.14-26

2015

Volltextzugriff (PDF)

Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities

Expert opinion on therapeutic targets, 2019-02, Vol.23 (2), p.87-91

2019

Volltextzugriff (PDF)

Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase

Oncotarget, 2017-12, Vol.8 (66), p.109915-109923

2017

Volltextzugriff (PDF)

Uncommon cytogenetic abnormalities identifying high-risk acute myeloid leukemia in children

Future oncology (London, England), 2020-11, Vol.16 (33), p.2747-2762

2020

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(88)

Sprache

Englisch
(88)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies

Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment

HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia

Identification of an Evolutionarily Conserved Family of Inorganic Polyphosphate Endopolyphosphatases

Targeted Therapies for Pediatric AML: Gaps and Perspective

Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias

The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis

B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?

Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML

Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway

hGATA1 Under the Control of a μLCR/β-Globin Promoter Rescues the Erythroid but Not the Megakaryocytic Phenotype Induced by the Gata1low Mutation in Mice

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors

IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia

Exploiting Clonal Evolution to Improve the Diagnosis and Treatment Efficacy Prediction in Pediatric AML

Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene

Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia

Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis

The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party

Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method

Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting

Successes and Challenges for Diagnosis and Therapy of Acute Leukemia

Autophagy in acute leukemias: A double-edged sword with important therapeutic implications

Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities

Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase

Uncommon cytogenetic abnormalities identifying high-risk acute myeloid leukemia in children

Suchergebnisse filtern